Navamedic ASA
OSE:NAVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Navamedic ASA
Common Shares Outstanding
Navamedic ASA
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Navamedic ASA
OSE:NAVA
|
Common Shares Outstanding
kr24m
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Photocure ASA
OSE:PHO
|
Common Shares Outstanding
kr26.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
V
|
Vistin Pharma ASA
OSE:VISTN
|
Common Shares Outstanding
kr44.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
10%
|
|
|
S
|
SoftOx Solutions AS
OSE:SOFTX
|
Common Shares Outstanding
kr2.2B
|
CAGR 3-Years
501%
|
CAGR 5-Years
209%
|
CAGR 10-Years
N/A
|
|
|
O
|
Oncoinvent ASA
OSE:ONCIN
|
Common Shares Outstanding
kr610k
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
|
Navamedic ASA
Glance View
Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo. The company went IPO on 2006-03-31. The firm in-licenses, acquires and markets pharmaceuticals and other healthcare products in northern Europe. The product portfolio includes original and generic pharmaceuticals, as well as food supplements, medical devices and other healthcare products. Navamedic ASA has three subsidiaries: Observe Medical, a Swedish medical technology company; Vitaflo Scandinavia AB, which focuses on in-licensing and buying pharmaceuticals and other healthcare products within a few selected knowledge areas; and Navamedic ehf, which builds its business around the sales and marketing of generic pharmaceuticals targeted towards the Nordic and BeNeLux markets. The Navamedic business unit is built upon the cooperation with the South African pharmaceutical company Aspen Healthcare. The Company’s largest shareholder is Nobelsystem Scandinavia.
See Also
What is Navamedic ASA's Common Shares Outstanding?
Common Shares Outstanding
24m
NOK
Based on the financial report for Dec 31, 2025, Navamedic ASA's Common Shares Outstanding amounts to 24m NOK.
What is Navamedic ASA's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
10%
Over the last year, the Common Shares Outstanding growth was 34%. The average annual Common Shares Outstanding growth rates for Navamedic ASA have been 12% over the past three years , 9% over the past five years , and 10% over the past ten years .
